IDYA
IDEAYA Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$31.99
+2.09%Margins
Gross margin
-304.7%
EBITDA margin
-1169.6%
EBIT margin
-1267.4%
Net margin
-1149.6%
FCF margin
-957.4%
-38.5%
Return on equity
-34.5%
Return on assets
-41.3%
Return on invested capital
0.03x
Asset turnover
-$347.4M
Cash from operations
$12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026